Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
11 studies found for:    ct-p13
Show Display Options
Rank Status Study
1 Active, not recruiting Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease
Condition: Crohn's Disease
Interventions: Biological: CT-P13;   Biological: Remicade
2 Completed An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1
Condition: Rheumatoid Arthritis
Intervention: Biological: Infliximab
3 Completed An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1
Condition: Ankylosing Spondylitis
Intervention: Biological: Infliximab
4 Not yet recruiting A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety Between Subcutaneous CT-P13 and Intravenous CT-P13 in Patients With Active Crohn's Disease and Active Ulcerative Colitis
Conditions: Crohn's Disease;   Ulcerative Colitis
Intervention: Biological: Infliximab
5 Recruiting Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease
Conditions: Inflammatory Bowel Disease;   Ulcerative Colitis;   Crohn's Disease
Intervention:
6 Completed Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)
Condition: Ankylosing Spondylitis
Intervention: Drug: Infliximab
7 Completed Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)
Condition: Rheumatoid Arthritis
Intervention: Drug: Infliximab
8 Active, not recruiting The NOR-SWITCH Study
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Psoriatic Arthritis;   Ulcerative Colitis;   Crohn's Disease;   Psoriasis Chronic
Interventions: Drug: Innovator infliximab;   Drug: Biosimilar infliximab
9 Recruiting An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention:
10 Recruiting An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA
Condition: Rheumatoid Arthritis
Intervention:
11 Recruiting To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)
Conditions: Crohn's Disease;   Ulcerative Colitis
Intervention:

Study has passed its completion date and status has not been verified in more than two years.